Display Settings:

Format

Send to:

Choose Destination

    Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5418-22.

    Cloning of a phospholipase A2-activating protein.

    Clark MA, Ozgür LE, Conway TM, Dispoto J, Crooke ST, Bomalaski JS.

    Smith Kline and French Laboratories, King of Prussia, PA 19479.

    Recently we have described the isolation and biochemical characterization of a phospholipase A2-activating protein (PLAP). We have cloned this protein and found it to be expressed as a 2.5-kilobase mRNA. The steady-state levels of PLAP mRNA are induced in smooth muscle and endothelial cells following treatment with leukotriene D4. The increased message levels coincide with increased amounts of PLAP. Synthetic antisense DNA was used to block the synthesis of PLAP and this treatment effectively blocked the activation of phospholipase A2 and the increased generation of prostanoids in smooth muscle and endothelial cells treated with leukotriene D4.

    PMID: 2052621 [PubMed - indexed for MEDLINE]

    PMCID: 51884

    Supplemental Content

    Click here to read